|
MechanismH1 receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United Kingdom |
First Approval Date11 Mar 1996 |
100 Clinical Results associated with Opella Healthcare (Shanghai) Co Ltd.
0 Patents (Medical) associated with Opella Healthcare (Shanghai) Co Ltd.
100 Deals associated with Opella Healthcare (Shanghai) Co Ltd.
100 Translational Medicine associated with Opella Healthcare (Shanghai) Co Ltd.